KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

GoodRx Holdings (GDRX) Return on Sales (2019 - 2026)

GoodRx Holdings' Return on Sales history spans 7 years, with the latest figure at 0.0% for Q4 2025.

  • On a quarterly basis, Return on Sales changed 0.0% to 0.0% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.0%, a 0.0% change, with the full-year FY2025 number at 0.0%, changed 0.0% from a year prior.
  • Return on Sales hit 0.0% in Q4 2025 for GoodRx Holdings, up from 0.0% in the prior quarter.
  • Over the last five years, Return on Sales for GDRX hit a ceiling of 0.0% in Q2 2023 and a floor of 0.0% in Q3 2022.
  • Historically, Return on Sales has averaged 0.0% across 5 years, with a median of 0.0% in 2025.
  • The widest YoY moves for Return on Sales: up 2bps in 2021, down 0bps in 2021.
  • Tracing GDRX's Return on Sales over 5 years: stood at 0.0% in 2021, then skyrocketed by 94bps to 0.0% in 2022, then tumbled by -1128bps to 0.0% in 2023, then skyrocketed by 126bps to 0.0% in 2024, then dropped by -18bps to 0.0% in 2025.
  • Business Quant data shows Return on Sales for GDRX at 0.0% in Q4 2025, 0.0% in Q3 2025, and 0.0% in Q2 2025.